Hosted on MSN1mon
Agenus reports promising sarcoma study resultsThe overall response rate (ORR) for the study population was 19.2%, with angiosarcoma patients showing a 27.8% ORR. The disease control rate (DCR) was 65.4%, with a median progression-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback